Delivery Order SPE2DB22D1017-SPE2DB25FYRUC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a contract ceiling value of $11,676.65. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,531.30 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCT 160-12.5 mg tablets (90-count) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,542.97 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a child delivery order under a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $77,079.86 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valsartan-HCTZ 320-12.5 mg tablets in quantities of 90 units. This firm fixed-price delivery order, which was not set-aside and competed openly, is scheduled for completion by September 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a quantity of 90 tablets, with a contract ceiling value of $1,393.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) with a ceiling value of $3,727.23. This is a firm fixed price, non-set-aside delivery order that represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $6,356.18 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) with a ceiling value of $6,919.39. The contract, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, utilizes firm fixed-price pricing and is not set-aside designated. The award is a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, which carries a...
- The Defense Logistics Agency awarded a delivery order valued at $1,913.12 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90 count) with a completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,300.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 160-12.5 mg tablets (90-count) on June 2, 2025, with completion scheduled for June 3, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRUCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Valsartan-HCL 320-25 mg tablets in quantities of 90 units, with a ceiling value of $6,299.54 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply comprehensive pharmaceutical products and medical supplies to support global military healthcare operations. The contract was competitively awarded with no set-aside designation and is scheduled for ultimate completion by September 25, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills essential medication needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's delivery order portfolio with DLA spans a diverse range of pharmaceutical products including diabetes medications, neurological treatments, pain management drugs, antibiotics, and specialty medical supplies, demonstrating its established capability to meet federal procurement requirements across multiple therapeutic domains. This particular delivery order for Valsartan-HCL, a common antihypertensive medication, exemplifies the routine pharmaceutical supply operations that support military and veteran healthcare systems through DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 9/24/25 |